BridgeBio Oncology Therapeutics

BBOTNasdaq United States Health Care Biotechnology: Pharmaceutical Preparations

Market cap

$747.399 M

$9.33 +6.26%

Close of 7 Aug 2026

Revenue

—

Not reported

Earnings

-$134.0M

Loss-making

Shares outstanding

80,032,823

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations — ranked by market cap

All 501 →

#181CytomX TherapeuticsCTMX$753.3M
#182Rigel PharmaceuticalsRIGL$750.4M
#183BridgeBio Oncology TherapeuticsBBOT$747.4M
#184Gyre TherapeuticsGYRE$743.6M
#185OculisOCS$735.2M

Where these numbers come from

Share counts and financials for BridgeBio Oncology Therapeutics are taken from its own SEC filings via EDGAR — public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 9 Aug 2026. Read the methodology.